What is Biovie Inc (BIVI) stock price today?

Biovie Inc (BIVI) currently trades at $1.65 per share. The stock has a market capitalization of $11.31M and a P/E ratio of —x.

Is BIVI stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Biovie Inc has a Smart Value Score of 27/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is -20.00.

Is Biovie Inc financially healthy?

Biovie Inc's Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of -20.00 places it in the distress.

BIVI

Biovie Inc

NASDAQ: BIVI · HEALTHCARE · BIOTECHNOLOGY

$1.65

+4.43% today

Updated 2026-04-30

Market cap

$11.31M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.28

Dividend yield

—

52W range

$1 – $13

Volume

0.1M

Market cap

$11.31M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-3.28

Dividend yield

—

52W range

$1 – $13

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

6.5

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

-20.0

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →204 stocks currently score above 75

Price targets

Analyst target

$12.00

+627.27%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Debt/equity 0.02x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Altman Z -20.00 — distress zone

- Thin margins at 0.00%

- Negative free cash flow $-4.44M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$0.00	$0.00	$0.00	$0.00	$0.00
Net income	$-26.08M	$-50.26M	$-32.12M	$-17.54M	$-6.07M
EPS	—	—	—	—	$-3.28
Free cash flow	$-18.99M	$-40.25M	$-27.95M	$-19.03M	$-4.44M
Profit margin	—	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
BIVI	$11.31M	27	4.3	3.0	5.0	6.5	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Biovie Inc trades at $1.65. Our Smart Value Score of 27/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of -20.00, it sits in the distress.

Frequently asked questions

What is Biovie Inc's stock price?

Biovie Inc (BIVI) trades at $1.65.

Is Biovie Inc overvalued?

Smart Value Score 27/100 (Grade F, Strong Sell).

What is the price target of Biovie Inc (BIVI)?

The analyst target price is $12.00, representing +627.3% upside from the current price of $1.65.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

-20.00 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

bioviepharma.com

Quick metrics

P/S ratio—

ROE-80.70%

Beta0.56

50D MA$1.38

200D MA$2.06

Shares out0.01B

Float0.01B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

BIVI vs LLY →BIVI vs JNJ →BIVI vs ABBV →Stock screener →